Neurizon inks $1.5M loan against R&D Tax Rebate
Neurizon Therapeutics (ASX:NUZ) retreated in intra-day trade on Wednesday after inking a non-dilutive loan agreement for $1.5 million to fund its current and future operations seeking to treat Huntington’s with its flagship drug NUZ-001.The funds in question are secured against it...
Market Cap $20.59M
!
Corporate Spotlight
Not Yet Available
Are you a Company Director ?
Put your Investment Case to Hotcopper's 700K monthly unique visitors.
Latest Threads
Tag | Subject | ||||||
---|---|---|---|---|---|---|---|
ICL | Ann: Quarterly Activities/Appendix 5B Cash Flow Report | 29/07/25 | 0 | 170 | |||
|
|||||||
ICL | Ann: Multi Target Drilling Program Underway at Guyer | 24/07/25 | 0 | 236 | |||
|
|||||||
ICL | Ann: Diamond Drilling Intersects High-Grade Gold at Guyer | 23/07/25 | 6 | 1.7K | |||
|
|||||||
ICL | Ann: High-Grade Drill Intersections Strengthen Guyer Gold Trend | 09/07/25 | 7 | 2.6K | |||
|
|||||||
ICL | Ann: Trading Halt | 04/07/25 | 44 | 14K | |||
|
|||||||
ICL | Ann: Notice Under Section 708A | 18/06/25 | 0 | 228 | |||
|
|||||||
ICL | Ann: Notification regarding unquoted securities - ICL | 18/06/25 | 0 | 240 | |||
|
|||||||
ICL | Ann: Application for quotation of securities - ICL | 18/06/25 | 0 | 258 | |||
|
See All Discussions
Timeline
![]() |
|
||||
![]() |
|
||||
![]() |
|
||||
![]() |
|
||||
![]() |
|
||||
![]() |
|
||||
View More |